πŸ‡ΊπŸ‡Έ FDA
Patent

US 11426380

Urolithins as immune response enhancers

granted A61KA61K2039/55A61K2039/55511

Quick answer

US patent 11426380 (Urolithins as immune response enhancers) held by Amazentis SA expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/55, A61K2039/55511, A61K31/335, A61K31/37